NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/26/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization18,714 mln
Float1,155 mln
Earnings Date08/10/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.78
Likely reliable
1-Year Forecast
17.81
Modest upside
Relative Strength
53
/ 100
Slightly ahead
Debt / Equity
0.98
Moderate leverage
Pre-Tax Margin
2%
Break-even
Business Description
Viatris is a global healthcare company founded in 1961 and based in Canonsburg, Pennsylvania, that sells a broad range of medicines across more than a dozen major markets worldwide, including North America, Europe, Asia, and the Middle East. Its product lineup spans branded drugs, generics, and biosimilars, addressing conditions such as heart disease, diabetes, cancer, and respiratory illness, and these are made available through pharmacies, wholesalers, insurers, and governments. The company also partners with other healthcare firms to develop new treatments and supports patients through educational resources and digital health tools.
